Bone Marrow Transplantation, 0268-3369
Journal
Publications
- 2018
- E-pub ahead of print
Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia
Charles Craddock, 31 May 2018, In: Bone Marrow Transplantation. 11 p.Research output: Contribution to journal › Review article › peer-review
- 2017
- Published
Allogeneic transplantation in primary refractory AML
Paul Ferguson & Charles Craddock, Jul 2017, In: Bone Marrow Transplantation. 52, p. 950-951Research output: Contribution to journal › Article › peer-review
- Published
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
Charles Craddock & 2 others, , Feb 2017, In: Bone Marrow Transplantation. 52, 2, p. 209-215 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Obituary: Professor David Grimwade (1962-2016)
Sylvie Freeman & Charles Craddock, Feb 2017, In: Bone Marrow Transplantation. 52, 2, p. 171-172 2 p.Research output: Contribution to journal › Article
- 2016
- Published
Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns, Emma Martin, Andrew Bell, Paul Moss, Charles Craddock, Christopher Fox & Sridhar Chaganti, Jun 2016, In: Bone Marrow Transplantation. 51, 6, p. 825-832Research output: Contribution to journal › Article › peer-review
- Published
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties
Charles Craddock, 1 Mar 2016, In: Bone Marrow Transplantation. 51, 3, p. 418-423 6 p.Research output: Contribution to journal › Article › peer-review
- 2015
- E-pub ahead of print
Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening
Charles Craddock, 5 Oct 2015, In: Bone Marrow Transplantation. 51, 2, p. 286-287 2 p.Research output: Contribution to journal › Letter › peer-review
- Published
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT.
Charles Craddock, 2015, In: Bone Marrow Transplantation.Research output: Contribution to journal › Article › peer-review
- Published
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
Charles Craddock, 2015, In: Bone Marrow Transplantation.Research output: Contribution to journal › Article › peer-review
- 2014
- Published
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma
May 2014, In: Bone Marrow Transplantation. 49, p. 671-678 8 p.Research output: Contribution to journal › Article › peer-review